1
|
Isaacson P and Wright DH: Malignant
lymphoma of mucosa-associated lymphoid tissue. A distinctive type
of B-cell lymphoma. Cancer. 52:1410–1416. 1983. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jaffe ES, Harris NL, Stein H, et al: World
Health Organization Classification of Tumors: Pathology and
Genetics of Tumorus of Haematopoietic and Lymphoid Tissues. IARC
Press; Lyon: 2001
|
3
|
Harris NL, Jaffe ES, Stein H, Banks PM,
Chan JK, Cleary ML, Delsol G, de Wolf-Peeters C, Falini B, Gatter
KC, et al: A revised European-American classification of lymphoid
neoplasms: A proposal from the International Lymphoma study group.
Blood. 84:1361–1392. 1994.PubMed/NCBI
|
4
|
Al-Hamadani M, Habermann TM, Cerhan JR,
Macon WR, Maurer MJ and Go RS: Non-Hodgkin lymphoma subtype
distribution, geodemographic patterns, and survival in the US: A
longitudinal analysis of the National Cancer Data Base from
1998–2011. Am J Hematol. 90:790–795. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Smith A, Howell D, Patmore R, Jack A and
Roman E: Incidence of haematological malignancy by sub-type: A
report from the Haematological Malignancy research network. Br J
Cancer. 105:1684–1692. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ferreri AJ, Guidoboni M, Ponzoni M, de
Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA,
Dal Cin E, Ieri R, et al: Evidence for an association between
Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer
Inst. 96:586–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Fung CY, Tarbell NJ, Lucarelli MJ,
Goldberg SI, Linggood RM, Harris NL and Ferry JA: Ocular adnexal
lymphoma: Clinical behavior of distinct World Health Organization
classification subtypes. Int J Radiat Oncol Biol Phys.
57:1382–1391. 2003. View Article : Google Scholar : PubMed/NCBI
|
8
|
Graue GF, Finger PT, Maher E, Rocca D
Della, Rocca R Della, Lelli GJ Jr and Milman T: Ocular adnexal
lymphoma staging and treatment: American joint committee on cancer
versus Ann Arbor. Eur J Ophthalmol. 23:344–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Jenkins C, Rose GE, Bunce C, Wright JE,
Cree IA, Plowman N, Lightman S, Moseley I and Norton A:
Histological features of ocular adnexal lymphoma (REAL
classification) and their association with patient morbidity and
survival. Br J Ophthalmol. 84:907–913. 2000. View Article : Google Scholar : PubMed/NCBI
|
10
|
Parikh RR, Moskowitz BK, Maher E, Rocca D
Della, Rocca R Della, Culliney B, Shapira I, Grossbard ML, Harrison
LB and Hu K: Long-term outcomes and patterns of failure in orbital
lymphoma treated with primary radiotherapy. Leuk Lymphoma.
56:1266–1270. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhou P, Ng AK, Silver B, Li S, Hua L and
Mauch PM: Radiation therapy for orbital lymphoma. Int J Radiat
Oncol Biol Phys. 63:866–871. 2005. View Article : Google Scholar : PubMed/NCBI
|
12
|
Harada K, Murakami N, Kitaguchi M, Sekii
S, Takahashi K, Yoshio K, Inaba K, Morota M, Ito Y, Sumi M, et al:
Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma
treated with radiation therapy: A long-term outcome in 86 patients
with 104 treated eyes. Int J Radiat Oncol Biol Phys. 88:650–654.
2014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Goda JS, Le LW, Lapperriere NJ, Millar BA,
Payne D, Gospodarowicz MK, Wells W, Hodgson DC, Sun A, Simpson R
and Tsang RW: Localized orbital mucosa-associated lymphoma tissue
lymphoma managed with primary radiation therapy: Efficacy and
toxicity. Int J Radiat Oncol Biol Phys. 81:e659–e666. 2011.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Bayraktar S, Bayraktar UD, Stefanovic A
and Lossos IS: Primary ocular adnexal mucosa-associated lymphoid
tissue lymphoma (MALT): Single institution experience in a large
cohort of patients. Br J Haematol. 152:72–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tran KH, Campbell BA, Fua T, MacManus M,
Ryan G, Chesson B and Wirth A: Efficacy of low dose radiotherapy
for primary orbital marginal zone lymphoma. Leuk Lymphoma.
54:491–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Suh CO, Shim SJ, Lee SW, Yang WI, Lee SY
and Hahn JS: Orbital marginal zone B-cell lymphoma of MALT:
Radiotherapy results and clinical behavior. Int J Radiat Oncol Biol
Phys. 65:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
17
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the committee on hodgkin's
disease staging classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
18
|
Stefanovic A and Lossos IS: Extranodal
marginal zone lymphoma of the ocular adnexa. Blood. 114:501–510.
2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Yahalom J, Illidge T, Specht L, Hoppe RT,
Li YX, Tsang R and Wirth A; International Lymphoma Radiation
Oncology Group, : Modern radiation therapy for extranodal
lymphomas: Field and dose guidelines from the international
lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys.
92:11–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Fowler JF: The linear-quadratic formula
and progress in fractionated radiotherapy. Br J Radiol. 62:679–694.
1989. View Article : Google Scholar : PubMed/NCBI
|
21
|
Fasola CE, Jones JC, Huang DD, Le QT,
Hoppe RT and Donaldson SS: Low-dose radiation therapy (2 Gy × 2) in
the treatment of orbital lymphoma. Int J Radiat Oncol Biol Phys.
86:930–935. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Hoskin PJ, Kirkwood AA, Popova B, Smith P,
Robinson M, Gallop-Evans E, Coltart S, Illidge T, Madhavan K,
Brammer C, et al: 4 Gy versus 24 Gy radiotherapy for patients with
indolent lymphoma (FORT): A randomised phase 3 non-inferiority
trial. Lancet Oncol. 15:457–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Pfeffer MR, Rabin T, Tsvang L, Goffman J,
Rosen N and Symon Z: Orbital lymphoma: Is it necessary to treat the
entire orbit? Int J Radiat Oncol Biol Phys. 60:527–530. 2004.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Kaushik M, Pulido JS, Schild SE and
Stafford S: Risk of radiation retinopathy in patients with orbital
and ocular lymphoma. Int J Radiat Oncol Biol Phys. 84:1145–1150.
2012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Kiesewetter B and Raderer M: Antibiotic
therapy in nongastrointestinal MALT lymphoma: A review of the
literature. Blood. 122:1350–1357. 2013. View Article : Google Scholar : PubMed/NCBI
|